Steve M. Sabus - Dec 5, 2022 Form 3 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Signature
/s/ Michael A. Metzger, Attorney-in-Fact
Stock symbol
SNDX
Transactions as of
Dec 5, 2022
Transactions value $
$0
Form type
3
Date filed
12/5/2022, 03:37 PM
Previous filing
Aug 17, 2022

No securities are beneficially owned.